Category: Prescription costs

Navigating prescription costs without insurance can be challenging, especially for essential medications. On average, the cash price for Trospium Chloride (60, 20mg tablets) without insurance can be around **$195.19**. However, this figure is often significantly higher than what you might actually pay with the right resources. Understanding **how much is trospium without insurance** is the first step towards finding affordable options.

As of January 2025, the list price for a 30-day supply of Orgovyx is $2,762.36, though the actual amount a patient pays can vary drastically based on their insurance coverage and eligibility for financial assistance. Understanding how much does a 30 day supply of Orgovyx cost requires looking beyond the official list price to consider all available programs and discounts.

The list price for a 30-day supply of Vraylar (cariprazine) was reported to be over $1,500 in early 2025, but the amount a patient actually pays for a 30-day prescription of Vraylar varies dramatically based on insurance coverage, pharmacy, and available savings programs. While the cash price is high, most patients do not pay the full retail amount, with many paying significantly less, or even nothing, with the right assistance.

Over 64 million prescriptions for gabapentin were dispensed in the United States in 2016 [1.9.2]. But how much is a prescription of 100 mg gabapentin? The price can vary significantly, often costing as little as $7.20 for 90 capsules [1.2.2].

The average retail price for a 60-tablet supply of 5mg Eliquis is significantly over $700, but using a free GoodRx coupon can reduce this expense by nearly 20%. For many patients, understanding what does the GoodRx cost for Eliquis is the first step toward making this vital medication more affordable.

The retail price for a 30-day supply of brand-name Valtrex can be hundreds of dollars without insurance, but generic versions offer substantial savings. Understanding how much is a 30 day supply of Valtrex involves knowing the difference between the brand and its more affordable generic equivalent, valacyclovir.

The FDA approved Zituvio (sitagliptin) for Type 2 diabetes in October 2023, introducing a new option to the market. Understanding **how much is Zituvio in the US** is crucial, as costs can vary dramatically depending on insurance, pharmacy, and whether you use coupons or a patient assistance program.